CROI 2017 Program and Information

Program and Agenda

Poster Sessions • Tuesday 1 Hosp Univ de Valme, Sevilla, Spain, 2 Hosp Univ de Donostia, San Sebastián, Spain, 3 Hosp General Univ de Alicante, Alicante, Spain, 4 Hosp German Trias i Pujol, Badalona, Spain, 5 Hosp de Basurto, Basurto, Spain, 6 Hosp General de Valencia, Valencia, Spain, 7 Hosp de La Línea, La Línea de la Concepción, Spain, 8 Hosp de Txagorritxu, Vitoria, Spain, 9 Hosp de Puerto Real, Puerto Real, Spain 539 PREDICTORS OF HEPATOCELLULAR CARCINOMA INHIV/HCV COINFECTED PATIENTSWITH CIRRHOSIS Aaron P. Thrift , Kathryn E. Royse, Christine Hartman, Jennifer R. Kramer, Elizabeth Chiao Baylor Coll of Med, Houston, TX 540 IFN-FREE THERAPY IS EFFECTIVE AND SAFE FOR HCV RECURRENCE IN LT HCV/HIV COINFECTION Christian Manzardo 1 , Maria Carlota Londoño 1 , Ana Moreno 2 , Lluis Castells 3 , Victoria Aguilera 4 , Jose R. Fernandez 5 , Jorge Calvo-Pulido 6 , Judith Peñafiel 1 , Antoni Rimola 1 , Jose M. Miro 1 1 Univ of Barcelona, Barcelona, Spain, 2 Hosp Ramon y Cajal, Madrid, Spain, 3 Hosp Univ Vall d‘Hebron, Barcelona, Spain, 4 Hosp Univ La Fe, Valencia, Spain, 5 Hosp Univ de Cruces, Barkaldo, Spain, 6 Hosp 12 de Octubre, Madrid, Spain 537 LIVERMICRORNA HSA-MIR-125A-5PMAY EXERT AN ONCOSUPPRESSOR EFFECT ONHCC Lorenzo Onorato 1 , Giorgio de Stefano 2 , Valentina Lodice 2 , Nunzia Farella 2 , Nicoletta Potenza 3 , Evangelista Sagnelli 1 , Aniello Russo 3 , Carmine Minichini 1 , Mario Starace 1 , Nicola Coppola 1 1 Second Univ of Naples, Naples, Italy, 2 AORN dei Colli, PO Cotugno, Naples, Italy, 3 Second Univ of Naples, Caserta, Italy 538 REAL-LIFE TREATMENT RATES FOR HEPATOCELLULAR CARCINOMA INHIV-INFECTED PATIENTS Nicolás Merchante 1 , Francisco Rodríguez-Arrondo 2 , Esperanza Merino 3 , Boris Revollo 4 , Sofía Ibarra 5 , Miguel García-Deltoro 6 , Francisco Téllez 7 , Joseba Portu 8 , Alberto Romero-Palacios 9 , Juan A. Pineda 1

541 RISK FACTORS OF ACUTE REJECTION AFTER LIVER TRANSPLANTATION INHIV+/HCV+PATIENTS

Christian Manzardo 1 , Sandra Silva Arrieta 2 , Antonio Rafecas 3 , Sandra Franco 2 , Santos del Campo 4 , Elisa Cordero 5 , Judith Peñafiel 1 , Antoni Rimola 1 , Christian Brander 2 , Jose M. Miro 1 1 Univ of Barcelona, Barcelona, Spain, 2 IrsiCaixa Inst for AIDS Rsr, Badalona, Spain, 3 L’Hosp de Llobregat, Spain, 4 Hosp Ramon y Cajal, Madrid, Spain, 5 Univ of Sevilla, Sevilla, Spain Barbara Menzaghi 1 , Carlo Magni 2 , Laura A. Nicolini 3 , Giovanni Cenderello 4 , Vito Fiore 5 , Maria Gussio 6 , Roberto Gulminetti 7 , Francesca Vichi 8 , Paolo Bonfanti 9 1 Busto Arsizio Hosp, Busto Arsizio, Italy, 2 ASST Fatebenefratelli, Milan, Italy, 3 Univ of Genova, Genova, Italy, 4 Galliera Hosp, Genoa, Italy, 5 Unit of Infectious Diseases, Sassari, Italy, 6 Garibaldi Hosp, Catania, Italy, 7 IRCCS Policlinico San Matteo Fndn Univ of Pavia, Pavia, Italy, 8 S. Maria Annunziata Hosp, Milan, Italy, 9 A. Manzoni Hospital, Lecco, Italy

542LB HCC DEVELOPMENT INHCV PATIENTS AFTER DAA: THE EXPERIENCE OF THE SCOLTA PROJECT

CROI 2017 96